2. In haemodialysis studies, diatrizoate and urea clearances showed a linear increase with increasing 'extracellular fluid' or plasma flow through the dialyser while the diatrizoatelurea clearance ratio fell.
excretion urography for the investigation of patients with severe oliguric and non-oliguric renal failure (Schwartz, Hurwitt & Ettinger, 1963;  Fry & Cattell, 1971 & Cattell, , 1972 . The safety of this investigation and the valuable information provided fully justify its increasing use (Grainger, 1972) . Because the contrast media in common use are primarily excreted by the kidneys (Denneberg, 1965; Donaldson, 1968; Cattell, 1970) and because there always remains the possibility of adverse systemic reactions to the drug (Berlyne & Berlyne, 1962; Ansell, 1970; McClennan, Kassner & Becker, 1972; Davies, Roberts & Roylance, 1975) , it has been recommended that high-dose excretion urography should only be carried out on patients with severe renal failure where facilities are available for treatment by dialysis (Saxton, 1969; Brown, Glancy, Fry & Cattell, 1970; Fry & Cattell, 1971 ; Grainger, 1972) . Because the diffusibility of contrast media has been little investigated we have examined the effectiveness of dialysis in the elimination of a commonly used contrast medium, sodium diatrizoate, both by peritoneal and haemodialysis.
Materials and methods

'Haemodialysis' study in vitro
Sodium diatrizoate is distributed throughout the extracellular fluid space (Denneberg, 1965) and exhibits little, if any, protein binding (Lasser, Farr, Fujimagari & Tripp, 1962) . Extracellular fluid was simulated by the use of a reservoir containing 15 1 of dialysis fluid (composition: sodium 130 mmolll, potassium 1.34mmol/l, calcium 1.65 mmol/l, magnesium 0.5 mmol/l, chloride 101 mmolll, acetate 35 mmol/l, lactate 1.3 mmol/l, glucose 10 mmolll) maintained at body temperature (37°C). Urea was added to this solution to a concentration of 84 mmol/l (500 mg/100 ml). To measure diatrizoate clearance, 30 yCi of 51-labelled sodium diatrizoate was added to the reservoir, and the contents were adequately mixed. Clearance was studied by using a two layer, single-pass standard Kiil dialyser, with an 1 1.5 ym cross-grain wet-stretched cuprophane membrane of area 1.0 m2. The simulated extracellular fluid was dialysed against dialysing fluid of the same electrolyte composition to which no urea or diatrizoate had been added. Dialysate flow rate was maintained at 500 ml/min; 'extracellular fluid' flow rate through the kidney was varied between 60 and 170 ml/min. The net transmembrane ultrafiltration pressure was maintained constant at 30 mmHg.
'Haemodialysis' study in vivo
Eleven oliguric patients were studied. All had endstage renal failure and were undergoing regular dialysis treatment in hospital. The patients were told of the nature and purpose of the investigation and all gave their informed consent. All studies were carried out during the course of routine dialysis with twolayer single-pass flat-plate dialysers, with 11 -5 fim cross-grain wet-stretched cuprophane membranes of area 1.0 m2, Six patients used standard Kiil dialysers and five patients used Meltec multipoint pyramid dialysers. Dialysate flow rate was maintained at 500 ml/min and net transmembrane ultrafiltration pressure was maintained constant at 100 mmHg. Blood flow through the dialyser was controlled by a Watson-Marlow MHRE blood pump, thus allowing deliberate variation in the flow rate. Each patient was given an intravenous injection of 30 yCi of sodium [1251] diatri~~ate, and after a 2 h equilibration period, blood samples were taken from the inlet and outlet lines of the dialyser, and the blood flow rate was measured by the bubble flow method (Jameson, 1968) . Three further pairs of samples were obtained from each patient at different rates of blood flow. The packed cell volume value used was the mean for each pair of samples.
Calculation of clearance
Peritoneal dialysis
Studies were carried out on five patients, who presented with acute oliguric renal failure and who required peritoneal dialysis for their management. The nature and purpose of the study having been explained, their consent was freely obtained.
Each patient was given 30 yCi of sodium [1251]-diatrizoate intravenously at least 12 h before measurement of peritoneal clearance. Clearance was measured with the patient fully established on dialysis, and 2 litre exchanges of dialysis fluid (Dialaflex 61) were made. The cycle time, measured from the start of inflow to completion of outflow, was recorded on each of three consecutive cycles. The fluid recovered from each cycle was collected separately, its volume measured, and an aliquot removed for urea and diatrizoate estimation. A blood sample was taken for urea and diatrizoate estimation at the midpoint of each cycle. In each patient the sequence was repeated on a separate occasion about 24 h later. Peritoneal clearance of urea and diatrizoate was calculated from the formula Peritoneal clearance (ml/min) = UV/Pt where U is the concentration of urea or diatrizoate (mmol/l) and V is the volume (ml) of the outflow fluid, P is the plasma concentration of urea or diatrizoate (mmolll) and t is the cycle time (min). The rate of peritoneal dialysis was expressed as the diaIysed volume (I/h) calculated by multiplying the inflow volume in litres (2) by 60 and dividing by the cycle time ( t ) in minutes.
The radioactivity of all samples was measured in a well-type scintillation counter, pulse-height analysis being used to detect the photopeak of *2sI, and urea was measured by Techniwn AutoAnalyzer.
Results
Haemodialysis in vitro
The relationship between urea and diatrizoate clearances and 'extracellular fluid' flow rate is shown in Fig. 1 . Both show a positive correlation with flow rate (urea, r = 0.986, P < 0.001 ; diatrizoate, r = 0.940, P <0.001). From the regression lines (method clearance 81.7 ml/min. Regression equations for the above data are presented at the end of this section.
The diatrizoatelurea clearance ratio shows a negative Correlation with flow rate in vitro (r = 0-882, PcO-001, Fig. 2 of least squares), at an 'extracellular fluid' flow rate of 100 ml/min, the diatrizoate clearance is 34.7 ml/min, and the urea clearance 68.2 ml/min.
Haemodialysis in vivo
Urea and diatrizoate clearances again showed a linear increase with increasing plasma flow both with the Kiil dialyser (urea, r = 0.938, P < 0.001 ; diatrizoate, r = 0.746, P<O.001) and the Meltec multipoint dialyser (urea, r = 0.945, P<O.OOl; diatrizoate, r = 0.953, P < 0*001). The urea and diatrizoate clearances obtained with the Kiil dialyser were slightly less than those obtained in the study in vitro. Thus, at a plasma flow rate of 100 ml/min, the diatrizoate clearance was 31.8 ml/min and the urea clearance 61.6 ml/min. Considerably greater clearances were obtained with the Meltec multipoint dialyser and at a plasma flow rate of 100 ml/min the diatrizoate clearance was 43.2 ml/mm and the urea In vivo, at a plasma flow rate of 100 mllmin, the diatrizoatelurea clearance ratio for the Kiil dialyser is 51.5% and for the Meltec multipoint dialyser 54%. Table 1 shows the mean diatrizoate and urea peritoneal clearances and the diatrizoatelurea clearance ratio for each patient. Four patients gave very similar results whereas one patient (J.H.) gave much higher values. The latter also differed in that he had undergone intermittent peritoneal dialysis 6 weeks before these measurements and had been treated for peritoneal infection on a number of occasions. The others were all studied during their initial dialysis. The mean diatrizoate clearance of all patients studied was 7.1 ml/min (SD 2-8), the urea clearance 13.8 ml/min (SD 3-3) and the diatrizoatelurea clearance ratio 49.8% 1.0) and 12.5 ml/min (SD 2.1) respectively, and the diatrizoatelurea clearance ratio 45.6% (SD 4-5). The peritoneal dialysis rate varied from 1.8 to 2.8 l/h. There was no correlation between dialysis rate and diatrizoatelurea clearance ratio.
Peritoneal dialysis
Regression equations
Kiil dialyser in vitro. Ureaclearance = 27.6 +0*41E (E is flow rate of 'extracellular fluid'). Diatrizoate clearance = 229 +0.120E. Diatrizoatelurea clearance ratio = 63.1 -0.117E. 
Kiil dialyser in
Discussion
The only published data on diatrizoate clearance by haemodialysis in vivo are those of Bahlmann & Kruskemper (1973) . Studying the decrease in total plasma iodine after the injection of meglumine sodium diatrizoate in eight patients undergoing haemodialysis on modified Kiil dialysers, they reported a whole blood clearance value of 52.9 +8
ml/min at a mean blood flow rate of 172 ml/min. in vivo and in oitro for the diatrizoatelurea clearance ratio allows studies to be undertaken in uitro for the evaluation of other dialysers. This is of some special interest as sodium diatrizoate has a molecular weight of 639 and hence lies within the range of 'middle molecules', which have been held to be responsible for uraemic toxicity in dialysed patients (Babb, Popovich, Christopher & Scribner, 1971) .
The diatrizoate clearance observed during peritoneal dialysis was considerably lower than during haemodialysis. This was not unexpected for the urea clearance was also much lower. The diatrizoateiurea clearance ratio for peritoneal dialysis (49 i 9 %) was very similar to that obtained during haemodialysis in the range of plasma flow from 100 to 150 mllmin.
There are only two previous reports of peritoneal clearance measurements in a total of six patients (Brooks & Barry, 1974; Milrnan & Christensen, 1974) . In the latter study of five patients a mean diatrizoate clearance of 10.7 ml/min was achieved but in two patients with the highest values hypertonic dialysis solutions were used, and in neither study was urea clearance measured.
Although the safety of high-dose excretion urography in renal failure is well established, provided that the patient is not dehydrated and conventional doses of contrast media are not exceeded (Grainger, 1972 , 1975) . Our studies have confirmed that, in the event of adverse reactions diatrizoate can be removed by both haemodialysis and peritoneal dialysis, the clearance in each case being approximately half that of urea. However, because of the relatively low clearance which can be obtained by peritoneal dialysis, rapid removal of diatrizoate requires haemodialysis.
In clinical practice the effectiveness of removal of a non-protein-bound substance is commonly expressed in terms of the plasma half-life (to.5). In patients with severe renal failure, the to.s for diatrizoate can be as long as 140 h, despite some extrarenal excretion (Van Waes, 1971 ). If we assume an extracellular volume, and hence distribution volume for sodium diatrizoate, of 15 1 in our patients we estimate that, at a plasma flow rate of 100 mllmin, the to.s with the Kiil dialyser would be 54 h, with the Meltec multipoint dialyser 4 h, and by peritoneal dialysis'between 24 and 30 h, exclusive of any extrarenal excretion.
It should also be noted that if dialysis becomes necessary during the course of excretion urography, e.g. before a final 24 h film (Fry & Cattell, 1971 ), haemodialysis will markedly affect the blood concentration of contrast and possibly the evolution of a delayed nephrogram or pyelogram.
